China’s trade surplus is triggering global unease — and India could emerge a winner

China ended 2025 with a record trade surplus of nearly $1.2 trillion, while April exports rose 14.1% year-on-year, intensifying global concerns about overcapacity and supply-chain dependence. Multinational firms are accelerating China+1 diversification toward India and Vietnam, which could create a long-term manufacturing opportunity for India despite persistent infrastructure, land, labor and regulatory bottlenecks. Sectors cited as best positioned include electronics, pharmaceuticals, auto components, textiles, specialty chemicals and engineering goods.

Analysis

The market is still underpricing how broad this becomes if it is structural rather than cyclical. The first-order trade is obvious: India gains incremental share in labor-intensive assembly, but the second-order winner is the ecosystem around it — logistics, industrial parks, power distribution, ports, specialty chemicals, and contract manufacturers that can absorb vendor relocation before headline FDI data shows up. The real alpha is in enablers with operating leverage to utilization, not in the obvious “India manufacturing” basket that already discounts policy optimism.

The bigger dynamic is not China losing all share; it is global buyers duplicating supply chains, which raises working capital, compliance, and capex intensity across the board. That hurts low-margin exporters and benefits firms that can offer speed-to-scale, certification, and multi-country sourcing support. Over 12-24 months, the biggest beneficiaries should be components and tooling suppliers that sit one step above final assembly, because those contracts are stickier and less politically visible than final-product headline wins.

The contrarian risk is that India’s opportunity may remain more a narrative than an earnings event if execution bottlenecks persist. If land, customs, logistics, and power reliability do not improve, capital can migrate to Vietnam, Mexico, or ASEAN alternatives with better near-term throughput, leaving India with announcements but not volume. In that scenario, the market would rotate from “India manufacturing” enthusiasm into skepticism within 2-3 quarters, especially if global demand softens and buyers revert to cheapest-supplier behavior.

Another underappreciated risk is policy retaliation from Beijing via price competition. If Chinese firms use excess capacity to aggressively undercut on export pricing, margins for new entrants can compress before scale is reached, delaying the payoff for fresh capex. That argues for selectively owning businesses with domestic demand buffers and balance-sheet strength, while avoiding pure-play exporters that need immediate utilization ramp to justify valuation.

Key Decisions for Investors

• Go long INDIA/INDA over 6-12 months as a basket expression of incremental manufacturing reallocation; pair with a short in a China-heavy Asia supply-chain proxy if risk budget allows, because the rerating should come from sustained capex flows rather than one-off headlines.
• Buy EPI / long Indian industrial enablers on a 6-18 month horizon, with preference for logistics, industrial real estate, and port-linked beneficiaries; target 15-25% upside if utilization inflects before earnings consensus catches up.
• Initiate a pair: long Indian electronics EMS/contract manufacturing names vs short low-margin China-dependent assemblers, looking for margin divergence as buyers diversify supply; hold until the first major order-book reallocation shows up in quarterly disclosures.
• Favor quality domestic-cyclical India names with manufacturing exposure over speculative pure-play exporters; the risk/reward is better where capex can be funded internally and earnings are less sensitive to a single customer ramp.
• Avoid chasing the theme via crowded large-cap India equity ETFs alone; use pullbacks tied to macro volatility to build exposure, because the better entry is likely on any disappointment in near-term execution data rather than on more policy headlines.